Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Caffeine
Drug ID BADD_D00332
Description Caffeine is a drug of the methylxanthine class used for a variety of purposes, including certain respiratory conditions of the premature newborn, pain relief, and to combat drowsiness. Caffeine is similar in chemical structure to [Theophylline] and [Theobromine].[A187691,L9851] It can be sourced from coffee beans, but also occurs naturally in various teas and cacao beans, which are different than coffee beans.[T716] Caffeine is also used in a variety of cosmetic products and can be administered topically, orally, by inhalation, or by injection.[T716] The caffeine citrate injection, used for apnea of the premature newborn, was initially approved by the FDA in 1999.[L9863] According to an article from 2017, more than 15 million babies are born prematurely worldwide. This correlates to about 1 in 10 births. Premature birth can lead to apnea and bronchopulmonary dysplasia, a condition that interferes with lung development and may eventually cause asthma or early onset emphysema in those born prematurely.[A187694] Caffeine is beneficial in preventing and treating apnea and bronchopulmonary dysplasia in newborns, improving the quality of life of premature infants.[T716]
Indications and Usage For management of fatigue, orthostatic hypotension, and for the short term treatment of apnea of prematurity in infants.
Marketing Status Not Available
ATC Code D11AX26; N06BC01
DrugBank ID DB00201
KEGG ID D00528
MeSH ID D002110
PubChem ID 2519
TTD Drug ID D0B3HD
NDC Product Code 41250-320; 21130-944; 65724-4012; 66715-5930; 55301-226; 63083-1508; 70677-0021; 76162-002; 49035-226; 58624-0306; 65724-4013; 38779-0419; 0363-5009; 56062-030; 53943-320; 41163-226; 11822-0691; 72036-020; 63941-020; 65724-4000; 51552-0200; 69842-509; 68016-680; 10267-5010; 66715-5830; 62959-955; 41520-708; 33992-2261; 0113-0409; 69842-500; 66715-5530; 50804-262; 46122-457; 58624-0308; 0363-0226; 58624-0310; 58624-0302; 66715-9799; 58624-0312; 36800-844; 0363-3440; 30142-726; 68210-4030; 11822-2260; 69168-076; 63868-114; 21130-226; 62959-954; 52389-155; 58624-0534; 49452-1320; 63940-229; 67091-117; 58624-0316; 72476-102; 57243-226; 37808-409; 52389-656; 62011-0340; 55319-226; 68998-076; 58624-0314; 70000-0154; 66715-5730; 58624-0304; 59779-345; 15579-201; 70000-0409; 55910-226; 46017-012; 52389-406; 65724-4004; 67751-160; 49483-343; 65724-4008; 56062-409; 41163-434
Synonyms Caffeine | 1,3,7-Trimethylxanthine | Vivarin | Caffedrine | Coffeinum N | Percutaféine | Dexitac | Durvitan | No Doz | Percoffedrinol N | Quick-Pep | Quick Pep | QuickPep | Coffeinum Purrum
Chemical Information
Molecular Formula C8H10N4O2
CAS Registry Number 58-08-2
SMILES CN1C=NC2=C1C(=O)N(C(=O)N2C)C
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
HepatotoxicityMetallothionein-1AP04731Not Available3823609; 3363219; 3704312
Metabolic acidosisAdenosine receptor A1Q60612Not Available25925253
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Acidosis14.01.03.002--
Aggression19.05.01.0010.000329%Not Available
Agitation19.06.02.001; 17.02.05.012--
Arrhythmia02.03.02.0010.000129%Not Available
Blood calcium increased13.11.01.003--Not Available
Blood creatine phosphokinase increased13.04.01.0010.000823%
Blood creatinine increased13.13.01.0040.000329%
Blood sodium increased13.11.01.013--Not Available
Brain hypoxia24.04.06.022; 22.02.02.010; 17.08.02.009--Not Available
Cardiac arrest02.03.04.0010.000343%
Cardio-respiratory arrest22.02.06.007; 02.03.04.0020.000215%Not Available
Cerebral haemorrhage24.07.04.001; 17.08.01.003--Not Available
Circulatory collapse24.06.02.0010.000086%Not Available
Completed suicide19.12.01.001; 08.04.01.0100.000215%Not Available
Deafness04.02.01.001--Not Available
Dermatitis23.03.04.002--Not Available
Disseminated intravascular coagulation01.01.02.002; 24.01.01.010--
Drug abuse19.07.02.0100.000601%Not Available
Dry skin23.03.03.001--
Dysarthria19.19.03.001; 17.02.08.0010.000329%
Dyspnoea22.02.01.004; 02.01.03.002--
Dystonia17.01.03.0010.000329%Not Available
Ear disorder04.03.01.001--Not Available
Eye swelling06.08.03.0030.000329%Not Available
Failure to thrive19.07.05.001; 18.04.01.003; 14.03.02.008--Not Available
Feeling jittery08.01.09.016--Not Available
Gastritis07.08.02.001--
Gastrointestinal disorder07.11.01.001--Not Available
Gastrointestinal haemorrhage24.07.02.009; 07.12.02.001--Not Available
Haemoglobin13.01.05.018--Not Available
The 1th Page    1 2 3 4    Next   Last    Total 4 Pages